Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160.
Bona
C
C
Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029.
Nixon
A
A
Kennedy
R
R
Zaghouani
H
H
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000534:Alum Compounds; D000818:Animals; D015686:Gene Products, env / Q000276:immunology*; D015483:HIV Antibodies / Q000096:biosynthesis*; D019302:HIV Envelope Protein gp160; D015497:HIV-1 / Q000276:immunology*; D051379:Mice; D010215:Papio; D010446:Peptide Fragments / Q000276:immunology*; D011498:Protein Precursors / Q000276:immunology*; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D054299:env Gene Products, Human Immunodeficiency Virus
D000276:Adjuvants, Immunologic; D000534:Alum Compounds; D015686:Gene Products, env; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; C078784:HIV envelope protein gp160 (503-535); D010446:Peptide Fragments; D011498:Protein Precursors; D054299:env Gene Products, Human Immunodeficiency Virus; C041524:aluminum sulfate; D014443:Tyrosine; C045245:stearyl tyrosine